Novel therapeutic agents to target escape mechanisms from anti-angiogenic treatment in Glioblastoma

  • Niclou, Simone (PI)
  • Cano Galiano, Andrés (PhD Student)

Project Details


Investigate the efficacy of newly identified targets induced by anti-angiogenic
treatment in GBM and develop a novel therapeutic alphabody approach.
AcronymCANBIO (Andres Cano Galiano)
Effective start/end date15/11/1614/11/20


  • FNR - Fonds National de la Recherche: €169,500.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.